tm logo
CRESILON
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 14 Feb 2022

Last Applicant/ Owned by

122 18th St

Brooklyn

NY

11215

Serial Number

88827234 filed on 09th Mar 2020

Registration Number

N/A

Correspondent Address

Tamara Carmichael

OLSHAN FROME WOLOSKY LLP

1325 AVENUE OF THE AMERICAS

NEW YORK NY 10019

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CRESILON

medical devices, both prescription and over-the-counter, for use in connection with humans and animals; Wound dressings, namely, rolled gauze, gauze pads, non-stick gauze pads, bandages, and adhesive pads; hemostatic agents in the nature of granules, powders, sheets, and fibers used for treating wounds; bandages for dressings; sponges for wound, burn, and surgery dressings; gauze; first aid kits

Classification Information


Class [005]
Pharmaceutical Products


medical devices, both prescription and over-the-counter, for use in connection with humans and animals; Wound dressings, namely, rolled gauze, gauze pads, non-stick gauze pads, bandages, and adhesive pads; hemostatic agents in the nature of granules, powders, sheets, and fibers used for treating wounds; bandages for dressings; sponges for wound, burn, and surgery dressings; gauze; first aid kits

Mark Details


Serial Number

No 88827234

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 010738-003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Feb 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
14th Feb 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
03rd Aug 2021FINAL REFUSAL E-MAILED
03rd Aug 2021NOTIFICATION OF FINAL REFUSAL EMAILED
03rd Aug 2021FINAL REFUSAL WRITTEN
30th Jun 2021TEAS/EMAIL CORRESPONDENCE ENTERED
29th Jun 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
29th Jun 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
29th Dec 2020NON-FINAL ACTION E-MAILED
29th Dec 2020NON-FINAL ACTION WRITTEN